Medical high pressure syringe market seen reaching $2.4 billion by 2030

The medical high pressure syringe market is projected to grow from $1.64 billion in 2025 to $2.4 billion by 2030 as CT and MRI use, diagnostic center expansion and minimally invasive procedures increase demand for precise contrast delivery. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Medical high pressure syringes support contrast delivery in CT and MRI imaging, making them important to diagnostic accuracy and workflow efficiency. - Market growth points to rising demand for advanced imaging tools as healthcare systems expand diagnostic capacity and move toward less invasive procedures. - The market’s projected rise to $2.4 billion by 2030 signals continued investment in imaging infrastructure and injector technology.

What happened: - The Business Research Company published a report on the global medical high pressure syringe market on Aug. 17, 2026. - The report values the market at $1.64 billion in 2025 and projects $1.77 billion in 2026. - The report forecasts the market will reach $2.4 billion by 2030. - The market is expected to grow at a 8.1% CAGR from 2025 to 2026 and 8.0% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - Medical high pressure syringes are specialized devices used to inject contrast agents during imaging procedures such as CT and MRI scans. - The syringes are designed to withstand elevated pressure for swift and controlled fluid delivery. - Accurate dosing is central to producing high-quality diagnostic images. - The report links historical growth to higher CT and MRI utilization, more diagnostic centers, the need for accurate contrast dosing, standardization of radiology workflows and upgrades to hospital imaging equipment. - Future growth drivers include minimally invasive diagnostic procedures, expanded imaging infrastructure, injector technology innovation, demand for faster imaging and more chronic disease diagnostics. - The report highlights trends including broader adoption in advanced diagnostic imaging, demand for high-precision contrast delivery systems, compatibility with syringeless injectors, greater emphasis on patient safety and a shift toward disposable high-pressure syringes. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The Business Research Company offers a free sample of the report at the sample report. - The company also provides the full report at the full market report.

Between the lines: - The forecast suggests imaging demand is shifting toward higher-precision delivery systems rather than basic contrast injection hardware. - The emphasis on syringeless injectors and disposable syringes points to a market balancing automation, safety and workflow speed. - Regional growth expectations suggest mature demand in North America and faster infrastructure buildout in Asia-Pacific. - Minimally invasive procedures are a meaningful demand driver because they rely on image guidance and precise contrast administration.

What's next: - The market is expected to continue expanding as imaging centers, hospitals and diagnostic workflows adopt newer injector systems. - Growth will likely track adoption of minimally invasive procedures and broader imaging infrastructure investment. - Vendors are likely to compete on precision, compatibility, safety features and disposability.